Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 11, 1996, Pages 1365-1372

  Wang, Xinkang ^a   Louden, Calvert ^a   Ohlstein, Eliot H ^a   Stadel, Jeffrey M ^a   Gu, Juan Li ^a   Yue, Tian Li ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

balloon angioplasty; osteopontin; platelet derived growth factor; smooth muscle cell

Indexed keywords

OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029910184     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.11.1365     Document Type: Article

References (26)

1. Butler WT. The nature and significance of osteopontin. Connect Tissue Res. 1989;23:123-136.
2. Giachelli CM, Schwartz SM, Liaw L. Molecular and cellular biology of osteopontin: potential role in cardiovascular disease. Trends Cardiovasc Med. 1995;5:88-95.
3. Giachelli CM, Bae N, Lombardi DM, Majesky MW, Schwartz SM. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991;177:867-873.
4. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
5. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macro-phage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994; 14:1648-1656.
6. Liaw L, Almeida M, Hart CH, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994;74: 214-224.
7. 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995; 95:713-724.
8. Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by β3 integrin. Exp Cell Res. 1994;214:459-464.
9. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
10. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem. 1990;265:10238-10243.
11. Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem. 1992;267:22806-22812.
12. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-derived growth factor-α and -β receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res. 1994; 75:682-691.
13. Wang XK, Feuerstein GZ, Clark RK, Yue TL. Enhanced leukocyte adhesion to interleukin-1β stimulated vascular smooth muscle cells is mainly through intercellular adhesion molecule-1. Cardiovasc Res. 1994;28:1808-1814.
14. Chang MY, Sasahara M, Chait A, Raines EW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. Arterioscler Thromb Vase Biol. 1995;15: 1631-1640.
15. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 1995;91:941-947.
16. Ohlstein EH, Douglas SA. Endothelin-1 modulates vascular smooth muscle structure and vasomotion: implications in cardiovascular pathology. Drug Devel Res. 1993;29:108-128.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
18. Wang XK, Lee G, Liebhaber SA, Cooke NE. Human cysteine-rich protein: a member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem. 1992;267: 9176-9184.
19. Singh K, Mukherjee AB, De Vouge MW, Mukherjee BB. Differential processing of osteopontin transcripts in rat kidney- and osteoblast-derived cell lines. J Biol Chem. 1992;267:23847-23851.
20. Rajchel A, Chan YT, Wool IG. The primary structure of rat ribosomal protein L32. Nucleic Acids Res. 1988;16:2347.
21. Wang XK, Yue TL, Barone FC, Feuerstein GZ. Demonstration of increased endothelial leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. Stroke. 1995;26:1665-1669.
22. Wang XK, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res. 1996;78:322-328.
23. Schwanz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
24. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Atherosclerosis. 1989;9:567-578.
25. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med. 1992;116:1292-1300.
26. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13: 1218-1226.